About
1.40SEK+0.00 +0.00%
Closed • Updated at 15:23 GMT+00:00Market Cap$17.09M
Volume84.1K
Beta0.35
RSI44.38
Alzecure Pharma Ab — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 20 2026
Last Patient has Completed AlzeCure's Phase Ib Clinical Study with NeuroRestore ACD856
Apr 8 2026
AlzeCure Pharma Publishes its Annual Report for 2025
Apr 7 2026
AlzeCure Pharma to Present at Redeye Healthcare Day on April 14
Apr 1 2026
AlzeCure Pharma to Present at Redeye Alzheimer's Theme Event on April 9
Mar 19 2026
AlzeCure Presents New Preclinical Data with NeuroRestore ACD856 at the Alzheimer's Conference AD/PD
Google Übersetzer